Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Orange at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer overall and live longer without the cancer growing or spreading than people who receive chemotherapy,
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this prostate cancer clinical trial in Orange, CA
If you're searching for prostate cancer treatment options in Orange, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.